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the VEGF expression on immunohisto-
chemistry and short survival of MPM.
Yasumitsu et al. reported in their ar-
ticle that patients with MPM demonstrated
higher levels of serum VEGF than those of
normal subjects. In addition, they also men-
tioned that patients group of MPM with
higher serum levels of VEGF had shorter
overall survival than those with lower level;
however, in their report, serumVEGF levels
showed significant tendencies to increase as
the clinical stage went up. Based on these
findings, it is supposed that patients with
higher serum levels of VEGF contained
more patients with advanced stage ofMPM.
These findings indicate that serum levels of
VEGF reflect the tumor burden or disease
progression of MPM. In such situation, the
prognostic significance should be examined
based on multivariate analysis as Cox re-
gression model, as in the report of Demirag
et al. At this point, we supposewe had better
be more cautious about the prognostic sig-
nificance of serum VEGF in MPM.
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How Do We Do It?
Another Optimal
Methodology for
Endobronchial
Ultrasound Sample
Handling
To the Editor:
We read with great interest the
article by Nakajima and Yasufuku1 in
the January issue of the Journal of
Thoracic Oncology. These authors re-
ported a methodology for analysis of
samples obtained by endobronchial ul-
trasound (EBUS), not only initially
developed for mediastinal staging of
non-small cell lung carcinoma
(NSCLC) but also widely used for the
initial diagnosis of mediastinal meta-
static lymph nodes. In this article, they
report a multidirectional analysis to
obtain precise diagnosis and molecular
testing, particularly emphasizing the criti-
cal use of freshly stored material.
We would like to report our own
experience of a cell aspirate freezing
method, allowing multiple cell analyses.
This method, although it presents certain
similarities with that described by Naka-
jima and Yasufuku, has a number of
notable differences.
Our sampling method has al-
ready been described.2 The entire pro-
cedure is performed by a cytopatholo-
gist for rapid on-site examination and
specimen handling. One to three
smears are performed for each aspi-
rate, and in the case of abundant ma-
terial, the extra aspirate is flushed into a
tube containing Roswell Park Memorial
Institute cell culture medium. After the
last aspirate, the needle is rinsed with
culture medium to obtain a cell suspen-
sion. Clots or tissue fragments, when
observed are removed, fixed in 10% for-
malin, and paraffin embedded for cell
blocks. Representativeness of cell sus-
pensions is checked by a stained cytos-
pin examination. Cell suspensions are
centrifuged, and cell pellets are frozen at
80°C in 20% dimethylsulfoxide
(Sigma, France) as usually performed
for cell lines: one to four frozen aliquots
are stored per specimen.
From March 16, 2007 to Decem-
ber 9, 2010, 450 patients underwent
conventional transbronchial needle aspi-
ration (TBNA; N  160) or EBUS-
guided TBNA (N  280). As systematic
storage at 80°C was started in May
2007, 425 cell aspirates have now been
frozen and stored (96% of all TBNA
performed over the last 38 months).
Two hundred sixteen of these stored
samples have been thawed for comple-
mentary techniques. The other samples
have been kept frozen for possible sub-
sequent analysis, if necessary.
When complementary tech-
niques are required, the samples are
thawed, and cytospin is performed to
check the quality of the cells. It must
be emphasized that this method of cell
freezing is usually associated with
very well-preserved cell morphology.
Depending on the suspected di-
agnosis, frozen and fresh cells can be
investigated by various methods. Flow
cytometry is used for the diagnosis of
lymphoma (lymphocyte immunotyp-
ing), small cell lung carcinoma (CD56
expression), or DNA ploidy. Tumor
cell differentiation markers (TTF1,
P63, CK7/CK20, estrogen receptors)
are studied in NSCLC or in patients
with a history of extrathoracic cancer,
either on smears, cytospins from fro-
zen cells or cell blocks. Molecular
analysis for EGFR and Ras mutations
is performed on thawed cell pellets in
NSCLC, and fluorescence in situ hy-
bridization analysis is performed on
cytospins from frozen cells.
In conclusion, we agree with Na-
kajima and Yasufuku that an optimal
methodology is essential for the man-
agement of specimens obtained by
EBUS-TBNA, particularly when rapid
on-site examination is not possible.
Fresh cell aspirates in cell culture me-
dium stored at 80°C in dimethylsulf-
oxide, which is a very simple method,
ensure optimal cell preservation for
morphology, allowing a wide range of
complementary techniques (flow cy-
tometry, molecular genotyping, etc.).
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